Strongbridge Biopharma plc SBBP
2.00 +2.00
Day range unavailable
52-week range unavailable
SBBP revenue history
Revenue is income from the company’s ordinary business activities.
30,731,000 USD
FY 2020 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | 30,731,000 | 9,019,000 | 41.54% |
| FY 2019 | 2019-12-31 | 21,712,000 | 3,685,000 | 20.44% |
| FY 2018 | 2018-12-31 | 18,027,000 | 10,981,000 | 155.85% |
| FY 2017 | 2017-12-31 | 7,046,000 | 7,046,000 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:16.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.